DNA testing in patients with GH deficiency at the time of transition

Growth Hormone and IGF Research

Volumn 13, Issue SUPPL. A, 2003, Pages

  Dattani, M T ^a  

^a GREAT ORMOND STREET HOSPITAL   (United Kingdom)

Author keywords

Combined pituitary hormone deficiency (CPHD); Growth hormone deficiency; Homeobox; Inheritance; Mutations; Septo optic dysplasia (SOD); Transcription factors

Indexed keywords

CORTICOTROPIN; DNA; GROWTH HORMONE; GROWTH HORMONE RELEASING FACTOR RECEPTOR; HOMEODOMAIN PROTEIN; HYDROCORTISONE; PROLACTIN; THYROTROPIN; TRANSCRIPTION FACTOR;

CEREBELLUM HYPOPLASIA; COMORBIDITY; CORTICOTROPIN DEFICIENCY; DNA DETERMINATION; DOMINANT INHERITANCE; GENETIC ANALYSIS; GROWTH HORMONE DEFICIENCY; HORMONE DEFICIENCY; HUMAN; HYDROCORTISONE RELEASE; HYPOPHYSIS DISEASE; MUTATIONAL ANALYSIS; NONHUMAN; PENETRANCE; PHENOTYPIC VARIATION; PITUITARY GLAND EXAMINATION; PRIORITY JOURNAL; RECESSIVE INHERITANCE; REVIEW; SEPTOOPTIC DYSPLASIA; TORTICOLLIS; X CHROMOSOMAL INHERITANCE;

EID: 0141630843     PISSN: 10966374     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1096-6374(03)00068-6     Document Type: Article

References (57)

1. J.S. Dasen, M.G. Rosenfeld, Signalling mechanisms in pituitary morphogenesis and cell fate determination, Curr. Opin. Cell Biol. 11 (1999) 669-677.
2. G. Couly, N.M. Le Douarin, The fate map of the cephalic neural primordium at the presomitic to the 3-somite stage in the avian embryo, Development 103 (Suppl) (1988) 101-113.
3. G.W. Eagleson, W.A. Harris, Mapping of the presumptive brain regions in the neural plate of Xenopus laevis, J. Neurobiol. 21 (1990) 427-440.
4. A.G. Jacobsen, D.M. Miyamoto, S.H. Mai, Rathke's pouch morphogenesis in the chick embryo, J. Exp. Zool. 207 (1979) 351-366.
5. J. Ericson, S. Norlin, T.M. Jessell, T. Edlund, Integrated FGF and BMP signaling controls the progression of progenitor cell differentiation and the emergence of pattern in the embryonic anterior pituitary, Development 125 (1998) 1005-1015.
6. D. Lazzaro, M. Price, M. de Felice, R. Di Lauro, The transcription factor TTF-1 is expressed at the onset of thyroid and lung morphogenesis and in restricted regions of the foetal brain, Development 113 (1991) 1093-1104.
7. N. Takuma, H.Z. Sheng, Y. Furuta, J.M. Ward, K. Sharma, B.L.M. Hogan, S.L. Pfaff, H. Westphal, S. Kimura, K.A. Mahon, Formation of Rathke's pouch requires dual induction from the diencephalon, Development 125 (1998) 4835-4840.
8. H.Z. Sheng, K. Moriyama, T. Yamashita, H. Li, S.S. Potter, K.A. Mahon, H. Westphal, Multistep control of pituitary organogenesis, Science 278 (1997) 1809-1812.
9. M. Treier, A.S. Gleiberman, S.M. O'Connell, D.P. Szeto, J.A. McMahon, A.P. McMahon, M.G. Rosenfeld, Multistep signaling requirements for pituitary organogenesis in vivo, Genes Dev. 12 (1998) 1691-1704.
10. H.Z. Sheng, H. Westphal, Early steps in pituitary organogenesis, Trends Genet. 15 (1999) 236-240.
11. R. Burgess, V. Lunyak, M. Rosenfeld, Signalling and transcriptional control of pituitary development, Curr. Opin. Genet. Dev. 12 (2002) 534-539.
12. D.M. Simmons, J.W. Voss, H.A. Ingraham, J.M. Holloway, R.S. Broide, M.G. Rosenfeld, L.W. Swanson, Pituitary cell phenotypes involve cell-specific Pit-1 mRNA translation and synergistic interactions with other classes of transcription factors, Genes Dev. 4 (1990) 695-711.
13. M.A. Japon, M. Rubinstein, M.J. Low, In situ hybridization analysis of anterior pituitary hormone gene expression during fetal mouse development, J. Histochem. Cytochem. 42 (1994) 1117-1125.
14. S. Li, E.B. Crenshaw, E.J. Rawson, D.M. Simmons, L.W. Swanson, M.G. Rosenfeld, Dwarf locus mutants lacking three pituitary cell types result from mutations in the POU-domain gene pit-1, Nature 347 (1990) 528-533.
15. H.A. Ingraham, D.S. Lala, Y. Ikeda, X. Luo, W.-H. Shen, M.W. Nachtigal, R. Abbud, J.H. Nilson, K.L. Parker, The nuclear receptor steroidogenic factor 1 acts at multiple levels of the reproductive axis, Genes Dev. 8 (1994) 2302-2312.
16. M.T. Dattani, J.-P. Martinez-Barbera, P.Q. Thomas, J.M. Brickman, R. Gupta, I. Mårtensson, H. Toresson, M. Fox, J.K.H. Wales, P.C. Hindmarsh, S. Krauss, R.S.P. Beddington, I.C.A.F. Robinson, Mutations in the homeobox gene HESX1/Hesx1 associated with septo-optic dysplasia in human and mouse, Nat. Genet. 19 (1998) 125-133.
17. P.Q. Thomas, B.V. Johnson, J. Rathjen, P.D. Rathjen, Sequence, genomic organization, and expression of the novel homeobox gene, Hesx1, J. Biol. Chem. 270 (1995) 3869-3875.
18. E. Hermesz, S. Mackem, K.A. Mahon, Rpx: A novel anterior-restricted homeobox gene progressively activated in the prechordal plate, anterior neural plate and Rathke's pouch of the mouse embryo, Development 122 (1996) 41-52.
19. J.S. Dasen, J.-P. Martinez-Barbera, T.S. Herman, S. O'Connell, L. Olson, B. Ju, J. Tollkuhn, S.H. Baek, D.W. Rose, M.G. Rosenfeld, Temporal regulation of a paired-like homeodomain repressor/TLE corepressor complex and a related activator is required for pituitary organogenesis, Genes Dev. 15 (2001) 3193-3207.
20. D.L. Reeves, Congenital absence of septum pellucidum, Bull Johns Hopkins Hospital 69 (1941) 61-71.
21. G. De Morsier, Etudes sur les dysraphies cranio-encephaliques. III. Agenesie du septum lucidum avec malformation du tractus optique. La dysplasie septo-optique, Schweiz. Arch. Neurol. Psychiatr. 77 (1956) 267-292.
22. W.F. Hoyt, S.L. Kaplan, M.M. Grumbach, J.S. Glaser, Septo-optic dysplasia and pituitary dwarfism, Lancet I (1970) 893-894.
23. S.A. Arslanian, Hormonal, metabolic and neuroradiologic abnormalities associated with septo-optic dysplasia, Acta Endocrinol. 107 (1984) 282-284.
24. N. Izenberg, M. Rosenblum, J.S. Parks, The endocrine spectrum of septo-optic dysplasia, Clin. Paediatr. 23 (1984) 632-636.
25. U. Roessman, Septo-optic dysplasia or de Morsier syndrome, J. Clin. Neurophthalmol. 9 (1989) 156-159.
26. C.A. Huseman, R.P. Kelch, N.J. Hopwood, W.B. Zipf, Sexual precocity in association with septo-optic dysplasia and hypothalamic hypopituitarism, J. Pediatr. 92 (1978) 748-753.
27. C.E. Hanna, S.H. Mandel, S.H. LaFranchi, Puberty in the syndrome of septo-optic dysplasia, Am. J. Dis. Child 43 (1989) 186-189.
28. K.S.L. Lam, C. Wang, J.T. Ma, S.P. Leung, R.T. Yeung, Hypothalamic defects in two adult patients with septo-optic dysplasia, Acta Endocrinol. 112 (1986) 305-309.
29. S. Yukizane, Y. Kimura, Y. Yamashita, T. Matsuishi, H. Horikawa, H. Ando, F. Yamashita, Growth hormone deficiency of hypothalamic origin in septo-optic dysplasia, Eur. J. Pediatr. 150 (1990) 30-33.
30. U. Roesmann, M.E. Velasco, E.J. Small, A. Hori, Neuropathology of "septo-optic dysplasia" (de Morsier syndrome with immunohistochemical studies of the hypothalamus and pituitary gland, J. Neuropathol. Exp. Neurol. 64 (1987) 597-608.
31. V.R. Nanduri, R. Stanhope, Why is the retention of gonadotrophin secretion common in children with panhypopituitarism due to septo-optic dysplasia?, Eur. J. Endocrinol. 140 (1999) 48-50.
32. B. Zaias, D. Becker, Septo-optic dysplasia: developmental or acquired abnormality. A case report, Trans. Am. Neurol. Assoc. 103 (1978) 273-277.
33. J.K.H. Wales, O.W.J. Quarrell, Evidence for possible Mendelian inheritance of septo-optic dysplasia, Acta Pediatr. 85 (1996) 391-392.
34. S.L. Blethen, V.V. Weldon, Hypopituitarism and septo-optic dysplasia in first cousins, Am. J. Med. Genet. 21 (1985) 123-129.
35. J.M. Brickman, M. Clements, R. Tyrell, D. McNay, K. Woods, J. Warner, A. Stewart, R.S.P. Beddington, M.T. Dattani, Molecular effects of novel mutations in Hesx1/HESX1 associated with human pituitary disorders, Development 128 (2001) 5189-5199.
36. P.Q. Thomas, M.T. Dattani, J.M. Brickman, D. McNay, G. Warne, M. Zacharin, F. Cameron, J. Hurst, K. Woods, D. Dunger, R. Stanhope, S. Forrest, I.C.A.F. Robinson, R.S.P. Beddington, Heterozygous HESX1 mutations associated with isolated congenital pituitary hypoplasia and septo-optic dysplasia, Hum. Mol. Genet. 10 (2001) 39-45.
37. A.B. Zhadanov, S. Bertuzzi, M. Taira, I.B. Dawid, H. Westphal, Expression pattern of the murine LIM class homeobox gene Lhx3 in subsets of neural and neuroendocrine tissues, Dev. Dyn. 202 (1995) 354-364.
38. H.Z. Sheng, A.B. Zhadanov, B. Mosinger Jr., T. Fujii, S. Bertuzzi, A. Grinberg, E.J. Lee, S.-P. Huang, K.A. Mahon, H. Westphal, Specification of pituitary cell lineages by the LIM-homeobox gene Lhx3, Science 272 (1996) 1004-1007.
39. H.Z. Sheng, K. Moriyama, T. Yamashita, H. Li, S.S. Potter, K.A. Mahon, H. Westphal, Multistep control of pituitary organogenesis, Science 278 (1997) 1809-1812.
40. I. Netchine, M.L. Sobrier, H. Krude, D. Schnabel, M. Maghnie, E. Marcos, B. Duriez, V. Cacheux, A. Moers, M. Goossens, A. Gruters, S. Amselem, Mutations in LHX3 result in a new syndrome revealed by combined pituitary hormone deficiency, Nat. Genet. 25 (2000) 182-186.
41. K. Machinis, J. Pantel, I. Netchine, J. Leger, O.J. Camand, M.L. Sobrier, F. Dastot-Le Moal, P. Duquesnoy, M. Abitbol, P. Czernichow, S. Amselem, Syndromic short stature in patients with a germline mutation in the lim homeobox Lhx4, Am. J. Hum. Genet. 69 (2001) 961-968.
42. K. Tatsumi, K. Miyai, T. Notomi, K. Kaibe, N. Amino, Y. Mizuno, H. Kohno, Cretinism with combined hormone deficiency caused by a mutation in the PIT1 gene, Nat. Genet. 1 (1992) 56-58.
43. S. Radovick, M. Nations, Y. Du, L.A. Berg, B.D. Weintraub, F.E. Wondisford, A mutation in the POU-homeodomain of Pit-1 responsible for combined pituitary hormone deficiency, Science 257 (1992) 1115-1118.
44. R.W. Pfaffle, G.F. DiMattia, J.S. Parks, M.R. Brown, J.M. Wit, M. Jansen, H. Van der Nat, J.L. Van den Brande, M.G. Rosenfeld, H.A. Ingraham, Mutation of the POU-specific domain of Pit-1 and hypopituitarism without pituitary hypoplasia, Science 257 (1992) 1118-1121.
45. W. Herr, R.A. Sturm, R.G. Clerc, L.M. Corcoran, D. Baltimore, P.A. Sharp, H.A. Ingraham, M.G. Rosenfeld, M. Finney, G. Ruvkun, H.R. Horvitz, The POU domain: a large conserved region in the mammalian pit-1, oct-1, oct-2, and Caenorhabditis elegans unc-86 gene products, Genes Dev. 2 (1988) 1513-1516.
46. S. Li, E.B. Crenshaw, E.J. Rawson, D.M. Simmons, L.W. Swanson, M.G. Rosenfeld, Dwarf locus mutants lacking three pituitary cell types result from mutations in the POU-domain gene pit-1, Nature 347 (1990) 528-533.
47. R.J. Duquesnoy, The pituitary dwarf mouse: a model for study of endocrine immunodeficiency disease, Birth Defects Orig. Artic Ser. 11 (1975) 536-543.
48. M.W. Sornson, W. Wu, J.S. Dasen, S.E. Flynn, D.J. Norman, S.M. O'Connell, I. Gukovsky, C. Carriere, A.K. Ryan, A.P. Miller, L. Zuo, A.S. Gleiberman, B. Andersen, W.G. Beamer, M.G. Rosenfeld, Pituitary lineage determination by the Prophet of Pit-1 homeodomain factor defective in Ames dwarfism, Nature 384 (1996) 327-333.
49. W. Wu, J.D. Cogan, R.W. Pfaffle, J.S. Dasen, H. Frisch, S.M. O'Connell, S.E. Flynn, M.R. Brown, P.E. Mullis, J.S. Parks, J.A. Phillips III, M.G. Rosenfeld, Mutations in PROP1 cause familial combined pituitary hormone deficiency, Nat. Genet. 18 (1998) 147-149.
50. J. Deladoey, C. Fluck, A. Buyukgebiz, B.V. Kuhlmann, A. Eble, P.C. Hindmarsh, W. Wu, P.E. Mullis, "Hot spot" in the PROP1 gene responsible for combined pituitary hormone deficiency, J. Clin. Endocrinol. Metab. 84 (1999) 1645-1650.
51. B.B. Mendonca, M.G. Osorio, A.C. Latronico, V. Estefan, L.S. Lo, I.J. Arnhold, Longitudinal hormonal and pituitary imaging changes in two females with combined pituitary hormone deficiency due to deletion of A301,G302 in the PROP1 gene, J. Clin. Endocrinol. Metab. 84 (1999) 942-945.
52. A.M. Procter, J.A. Phillips III, D.N. Cooper, The molecular genetics of growth hormone deficiency, Hum. Genet. 103 (1998) 255-272.
53. Y. Takahashi, H. Kaji, Y. Okimura, K. Goji, H. Abe, K. Chihara, Brief report: short stature caused by a mutant growth hormone, N. Engl. J. Med. 334 (1996) 432-436.
54. J. Deladoey, P. Stocker, P.E. Mullis, Autosomal dominant GH deficiency due to an Arg183His GH-1 gene mutation: clinical and molecular evidence of impaired regulated GH secretion, J. Clin. Endocrinol. Metab. 86 (2001) 3941-3947.
55. C.T. Moseley, P.E. Mullis, M.A. Prince, J.A. Phillips III, An exon splice enhancer mutation causes autosomal dominant GH deficiency, J. Clin. Endocrinol. Metab. 87 (2002) 847-852.
56. M.P. Wajnrajch, J.M. Gertner, M.D. Harbison, S.C. Chua Jr., R.L. Leibel, Nonsense mutation in the human growth hormone-releasing hormone receptor causes growth failure analogous to the little (lit) mouse, Nat. Genet. 12 (1996) 88-90.
57. H.G. Maheshwari, B.L. Silverman, J. Dupuis, G. Baumann, Phenotype and genetic analysis of a syndrome caused by an inactivating mutation in the growth hormone-releasing hormone receptor. Dwarfism of Sindh, J. Clin. Endocrinol. Metab. 83 (1998) 4065-4074.